Media Center

Seegene Donates Emergency Relief Funds to ChildFund Korea for Nepal Climate Disaster Recovery

Seegene Proposes Comprehensive Reproductive Tract Infection Testing Approach through the Global Million Clinical Study

Seegene USA Receives FDA Emergency Use Authorization for Multiplex PCR Assay, Advancing Differential Diagnosis of HSV-1&2, VZV, and Monkeypox Virus for Ulcerative Skin Lesions

Seegene: “Virus-Only Testing May Miss Pneumonia-associated Bacterial Respiratory Pathogens” Calls for a Shift to Comprehensive Syndromic PCR Testing

Seegene Launches Industry’s First Global Million Clinical Study to Shape New Disease-Specific Testing Standards

Seegene Launches Allplex™ MDRO Assay Under IVDR: Expanding AMR Testing Portfolio in Europe

Seegene Introduces STAgora at ESCMID Global 2026, Highlighting Real-Time Data with Automated PCR Workflows

Seegene Establishes French Subsidiary to Expand European Footprint

Seegene and Springer Nature Open Applications for 2025-2026 Nature Awards MDx Impact Grants

Seegene Unveils CURECA™ and STAgora™ at ADLM 2025, Advancing the Next Stage of Diagnostics

Seegene Launches STAgora™, a New Platform for Infectious Disease Analytics

Seegene’s CURECA™ Emerges as a Potential Game Changer in End-to-End PCR Automation